Regulation of Uterine Smooth Muscle Function during Gestation

Abstract

The uterus is unique among smooth muscular organs in that, during pregnancy, it undergoes profound, largely reversible, changes orchestrated by the ovarian hormones. These changes facilitate uterine adaptation to the stretch induced by the growing fetus such that a state of myometrial contractile quiescence can be maintained. This quiescent state usually is maintained until fetal development is sufficient for extrauterine life, at which point unknown mechanisms precipitate conversion to a highly contractile state. Throughout pregnancy, signaling mechanisms for myometrial contractility are altered-first to promote quiescence and then again to promote contractions. The mechanisms responsible for these changes are only partially understood. This review attempts to summarize salient features of many of the changes in uterine contractile signaling and the current state of ongoing investigations of their mechanisms. We have also highlighted some newer information and concepts from nonuterine tissues, which we believe may provide insight into the control of uterine smooth muscle function. Some detail has been omitted, and can be found in the many excellent reviews cited. We hope that this discussion may stimulate the interests of other investigators. The diverse areas of inquiry offer hope that this decade will lead to a fuller understanding of myometrial function and the development of vastly improved approaches for the control of preterm labor.

Main

The uterus undergoes many changes during pregnancy and must achieve enormous expansion to accomodate the growing fetus, and to support the fetus through sustained muscle tone, without generating propagated contractions. This state of quiescence-the absence of coordinated contractions-is critical to the successful outcome of pregnancy, but remains poorly understood. The delicate balance between maintenance of tone and resistance to propagated contractions continues to the end of gestation and the onset of labor, when the uterus becomes active and empties its contents through rhythmic, forceful, organized contractile waves. In this review, we discuss the mechanisms governing these responses and new insights into their regulation during pregnancy. We focus on emerging areas of research and cite recent review articles concerning well studied areas.

UTERINE SMOOTH MUSCLE: FUNCTIONAL STRUCTURE

Cellular

The four main types of smooth muscle tissue are distinguished by the type of contraction (tonic or phasic) and whether or not the muscle is excitable by electrical stimulation (i.e. generates an action potential (1). Uterine smooth muscle is highly excitable, and normally undergoes spontaneous rhythmic contractions that vary in frequency and amplitude. The nature of the regional variation in spontaneous contractile activity in the uterus is not known. Specialized pacemaker cells have been hypothesized as the initiators of activity, but have not been characterized; spontaneous activity may be a property of many myometrial muscle cells, with sites of initiation of electrical activity throughout the myometrium (24).

For a multicellular muscle to contract as an organ, the contraction of individual cells must be coordinated by sequential depolarization of cells. The uterus contracts as a three-dimensional system of cells, the individual responses of which are communicated to neighbors in a distinct pattern. Depolarization of one cell leads to activation of only neighboring nondepolarized cells, so that a wave of activation proceeds in a specific direction, a process required for organized contractions and thus transportation of the uterine contents. During gestation, this coordination is far less effective than during labor, allowing gestation to be maintained. However, abortion can be induced by strong pharmacologic stimulation at any point in gestation, indicating that ineffective electrical coupling can be surmounted. Therefore, the inhibition is relative rather than absolute, and the ability to respond is maintained.

Contractile Apparatus

Although largely considered an obligatory step in excitation-contraction coupling, activation of the contractile apparatus-the actin-activated myosin ATPase-recently has been recognized as a regulated process. Moreover, changes in components of the contractile apparatus exert significant effects on the ability of Ca2+ to activate contraction (5,6). Ca2+ - and calmodulin-activated MLC kinase is the principal control mechanism for contractility, and the intracellular level of ionized Ca2+ is the most important controlling feature [reviewed in Bárány and Bárány (7)]. However, other actin-related proteins, troponins, caldesmon, and perhaps calponin also are phosphorylated under physiologic conditions and regulate Ca2+-sensitivity of the contractile apparatus, allowing a finer degree of control of the response to a given Ca2+ level (6). This so-called "thin-filament-based" regulation enables smooth muscle cells to adjust the amount of force developed in response to the same Ca2+ level. Moreover, thin filament-based regulation may explain how force is maintained when levels of MLC (20 kD) phosphorylation or of Ca2+ are low. This mechanism could be important to both maintenance of gestational quiescence and subsequent augmentation of coordinated contractility during labor. For example, stretch has been found to increase the expression of caldesmon, an inhibitory molecule, in the uterus (5). Much work is now being done to elucidate the role of these regulatory mechanisms in uterine contractile function (6).

Another emerging area of interest is the role of small GTP-binding proteins, such as RhoA and Rac-1, relatives of Ras, which regulate the assembly of filamentous, nonmuscle actin, leading to alterations in cell shape as well as capacity for force development. Force development (i.e. contractility) at a given level of activation (by Ca2+) is determined in part by the extent of attachment (focal adhesive contacts) between actin and the intermediate filaments of the cytoskeleton within cells, as well as to other muscle cells. Increased numbers of focal contacts provide a stiffer scaffold and result both in enhanced force transfer from cell to cell as well, and in increased shortening length and force development. Further, increased MLC phosphorylation should enhance smooth muscle contractility, as predicted by studies demonstrating that intracellular Ca2+ concentration is not always a good predictor of either myosin phosphorylation or contractility. The relevance of this mechanism to smooth muscle contraction became apparent with the discovery that RhoA can regulate myosin phosphorylation (8)-the critical step controlling cross-bridge cycling rate in contraction. The interaction of RhoA and the MLC regulatory subunit of MLC-P leads to inhibition of MLC-P activity, thereby increasing myosin phosphorylation and hence contraction and/or stress fiber formation (Fig. 1). Guanosine 5′-O-(thiotriphosphate) can increase MLC phosphorylation through the inhibition of MLC-P, and RhoA may be involved. RhoA interacts with protein kinase N (related to protein kinase C) and with Rho kinase. Both kinases become activated upon interaction or binding with GTP-bound (active) RhoA. Kimura et al. (8) discovered that Rho-kinase phosphorylates the catalytic subunit of MLC-P, which prevents activation of MLC-P by the regulatory subunit, possibly by facilitating release of MLC-P from the catalytic subunit. Thus the general concept (9) is that Rho activation (possibly by growth factor-mediated signaling events) leads to its redistribution to the plasma membrane and subsequently the interaction with or recruitment of protein kinase N, Rho kinase, and their substrates (which already may be at the membrane). Still unclear is the turn-off mechanism for this, which likely would involve activation of RhoA's guanosine triphosphate hydrolase via guanosine triphosphate hydrolase-activating proteins. Interestingly, the attachment sites for stress fibers, the focal adhesions, are the points at which the cytoskeleton communicates with the extracellular matrix via the integrin receptors; thus, one might expect that force changes could signal through the integrin receptors, possibly to regulate the RhoA signaling mechanism in a feed-back of feed-forward manner. Levels of RhoA and Rac-1 are increased more than 3-fold in myocytes from pregnant human uterus (versus nonpregnant) (10), and in the rat uterus, OT stimulation or KCl depolarization increases translocation of RhoA from the sarcolemma to the cytoskeleton (11). These observations suggest that the RhoA-based signaling pathway may promote enhanced contractility at term.

Figure 1
figure1

Pathways regulating MLC-P activity, and thereby myosin phosphorylation, and hence contraction and/or stress fiber formation. This figure depicts the roles of small GTP-binding proteins in the activation of smooth muscle myosin ATPase-to cause shape changes or contraction-through effects exerted on MLC-P. The key concept is that dephosphorylation of MLC (i.e. phosphatase activity) rather than MLC kinase activity is the target of regulation, but the end result is increased MLC phosphorylation and subsequent crossbridge cycling via the myosin ATPase. Activation of Receptor A (perhaps by contractile agonists or growth factors) promotes GTP binding to RhoA, which then can bind to and activate Rho-kinase. Rho-kinase-mediated phosphorylation of the MLC phosphatase's regulatory subunit causes an inhibition of the phosphatase, allowing increased levels of phosphorylated MLC and increased contractility. ECM, extracellular matrix; FAK, focal adhesion kinase; GAPs, guanosine triphosphate hydrolase activating proteins; GEFs, GDP-GTP exchange factors; MBS MLC-P regulatory subunit; MLCK, MLC kinase; the circled P indicates phosphorylated MLC.

MECHANISMS OF CONTRACTION

Membrane Potential Controls Myocyte Responsiveness

Depolarization of the uterine smooth muscle cell (i.e. membrane potential is made more positive relative to the resting state) occurs when an action potential is initiated through the regenerative influx of cations. In nerve cells Na+ ions carry the bulk of the action potential current, but in smooth muscle cells, the depolarizing action potential current is carried by Ca2+ ions, which enter via voltage-gated Ca2+ channels [reviewed in Wray (12)]. The repolarization phase of the action potential is the result of both K+ ion efflux and the inactivation of Ca2+ channels as potential drops. Although still poorly understood, pacemaker-generated action potentials likely are initiated through instability of membrane permeability to Na+ (increased) or, possibly, K+ (decreased). Depolarization is a function of the resting membrane potential, and is blocked if the potential is sufficiently negative relative to the resting potential, i.e. hyperpolarized. Pharmacologic agents can also activate (or inhibit) ion channel activities, and stimulate (or inhibit) contractile activity. The role of Ca2+ is discussed below.

Calcium-Mediated Contractile Activation

A variety of hormones, neurotransmitters, and pharmacologic agents influence the contractile state of uterine smooth muscle cells [reviewed in Fuchs (13)]. Ultimately, the ability of any of these agents to affect response is governed by the final common pathway of Ca2+ ion mobilization, which couples excitation to contraction. Activation causes the intracellular concentration of ionized free Ca2+ to rise from a resting level of 130 nM (14) toward the 200-400 nM level, enabling Ca2+-activated MLC kinase to increase myosin ATPase activity and cross-bridge cycling and muscle cell shortening [reviewed in Word (5) and Bárány and Bárány (7)]. Immediately after elevation of intracellular Ca2+ levels, homeostatic mechanisms act to restore the resting condition by active removal of the excess Ca2+ from the interior through energy-driven extrusion mechanisms (pumps) and channels present in the membranes of intracellular Ca2+ storage sites (SR) and in the plasmalemma.

Calcium entry. Ca2+ mobilization is regulated through channels that gate ion flux through the plasmalemmal and SR membranes. The plasmalemmal channels can be activated by electrical changes (voltage-operated channels), receptors/second messengers (e.g. putative G protein-coupled channels), and forces such as stretch and pressure (see below).

Calcium channels. The properties of myometrial ion channels and their regulation by voltage and agonist-occupied receptors have been reviewed recently (15). The actions of channel-specific inhibitors indicate a major role for both Ca2+ and K+ channels in controlling uterine contractility (Fig. 2). Specifically, the L-type (dihydropyridine-sensitive or dihydropyridine receptor) VOC, and the high conductance Ca2+-activated K+ channels ("maxiK" or "KCa"), related to the Drosophila "slo" channel (16), exert the greatest influence on intracellular Ca2+ ion concentration and contractility in myometrium. VOC and KCa channels operate in a reciprocal manner. Depolarization-induced VOC activation causes Ca2+ influx, and the increased intracellular Ca2+ levels activate KCa channels, permitting K+ efflux and restoration of membrane potential, thereby inactivating the VOC. In the interval between the completion of these two cycles, the muscle cell contracts, and if chemical activators remain available to their receptors, the activation phase is repeated in a cyclical manner.

Figure 2
figure2

Roles of Ca2+ and K+ channels in controlling smooth muscle activity/contractility and relaxation. The two types of channels are thought to act in a reciprocal manner to control contractility. Calcium entry via the dihydropyridine receptor/VOC activates the contractile apparatus and also activates Ca2+ release from SR stores, providing a locally elevated Ca2+ concentration in the region of sarcolemmal KCa channels. The locally elevated Ca2+ (sparks) are sufficient to activate KCa channels, which repolarize the sarcolemma through potassium efflux, and thereby eliminate the voltage potential driving the VOCs. DHPR, dihydropyridine receptor; TEA, tetraethylammonium chloride.

Quantal Ca2+ release. Recently, a much clearer picture has emerged [reviewed in Bootman and Berridge (17) and Berridge (18)] of the mechanisms of fine control of Ca2+ mobilization in smooth muscle and other cell types. Ca2+ is released from intracellular storage sites in quantal units, variously called "sparks" or "STOCs" (spontaneous transient outward currents) in muscle cells and "puffs" or "bumps" in nonmuscle cells. The receptors/channels responsible for these types of Ca2+ release are the SR RyR (Figs. 2 and 3) and the IP3R (Fig. 3), respectively. The RyRs are activated by Ca2+ flowing through VOCs, whereas IP3Rs are activated by receptor-linked PLC activation. These release receptors have two important properties. They have a bell-shaped sensitivity to Ca2+; low concentrations prompt more Ca2+ release (positive feed-back), whereas at high concentrations (> micromolar), release is inhibited (negative feedback). The positive feedback mechanism also has been called "Ca2+-induced Ca2+ release." The brief (70-500 ms) punctate Ca2+ release events occur just beneath the plasma membrane and produce only small current fluctuations because they activate only local neighboring ion channels (possible only one or a few clustered channels). Although small, the "sparks" are thought to play a major role in the generation of global Ca2+ signals within the cell through the recruitment of VOCs. In the myocardium, SR Ca2+ sparks now are thought to be initiated through the intimate association of the VOCs in the T-tubule invaginations of the sarcolemma with the subjacent RyRs of the SR, the VOC-derived Ca2+ serving to activate sufficient RyRs to activate global Ca2+ release from the SR (19). In smooth muscle, low intensity global signals stimulate contraction, whereas conversely, focused high intensity signals (e.g., "sparks") in the submembranous region bring about relaxation. In other tissues, receptor activation leads to a proportionate increase in IP3 concentration, which increases both the frequency of sparks and the Ca2+ sensitivity of the neighboring IP3Rs. This acts to coordinate the release of the sparks and results in their summation as waves of Ca2+. The progressive recruitment process allows graded responses despite the regenerative or positive feedback nature of the spark. Most important is the spatial segregation of Ca2+ signals. For example, in arterial smooth muscle, the global elevation of Ca2+ levels (waves) triggers contraction, whereas sparks produced by RyR located near the sarcolemma cause relaxation. This elaborate interaction between IP3R and RyR to control Ca2+ levels, and thus smooth muscle tone, has been described recently (Fig. 2) (17,20). The concept is that increased intracellular Ca2+ concentrations, as a result of VOC and IP3R activation, lead to increased SR Ca2+ content, which increases the frequency and amplitude of spark emissions from the RyR. Because these sparks are located near the sarcolemma, they can activate KCa channels, which act to restore local membrane potential and thereby feedback inhibit VOC activation. The proposed feedback mechanism to restore resting tension is conceived of as acting in parallel with the homeostatic Ca2+ restorative systems (pumps and uptake mechanisms). These models provide an important framework for understanding the dynamics of myometrial tone throughout gestation, and suggest several potential sites of action for the mediators of pregnancy-induced changes. The functional aspects of myometrial smooth muscle SR are still poorly understood (12). Further studies will be needed to determine the relevance of the calcium spark mechanisms to myometrial function, although it serves at least as a useful conceptual model. At least two subtypes of the RyR are reported to be expressed at the mRNA level in near-term human myometrium (21).

Figure 3
figure3

Mechanisms of fine control of intracellular Ca2+ mobilization in smooth muscle; role of receptors/channels. When SR Ca2+ stores are depleted, IP3R activation is coupled to activation of store-operated Ca2+ channel, leading to replenishment of SR Ca2+ stores. cADPR, cyclic ADP ribose; CICR, Ca2+-induced Ca2+ release; ROC, receptor-operated Ca2+ channel; OC, store-operated Ca2+ channel.

Potassium Channels

High conductance KCa channels regulate contractility in vascular (22) as well as uterine smooth muscle (2325). Of note, cAMP-generating agents (e.g. β-adrenergic agonists) (15), cGMP-generating agents (e.g. NO) (26), and NO itself, through an apparently direct effect (27), all activate KCa channels to promote relaxation. Current research is directed at understanding the mechanisms through which these agents regulate KCa channels in terms of the roles of receptor-channel coupling, channel phosphorylation, and modification of critical sulfhydryl groups by oxygen radicals such as NO in the regulation of this channel. The molecular identify of the KCa channel has been determined (28), but little is known about K+ channel expression in the myometium, although functional differences in KCa channels present in laboring versus nonlaboring human myometrium have been reported (29).

Another type of K+ channel, the ATP-sensitive K+ channel, also affects the contractility of uterine and other smooth muscles, probably by NO release as well as by other mechanisms. A voltage-sensitive K+ channel with distribution in heart and uterus has been identified through molecular homology studies (30), and may have a function in the labor process (see below).

Stretch and Force-Mediated Signaling

Stretch can induce contraction of the myometrium (31) and other muscles. The mechanisms of stretch-induced activation have been studied most extensively in myocardium [reviewed in Crozatier (32)]. Stretch-activated ion channels, the open time of which is increased upon stretch or deformation (e.g. due to pressure or shear stress), are still poorly understood, but are thought to gate Cl- (33) or Na+ (34) ions. The stretch-induced Ca2+-mobilization process may involve activation of a Gi-coupled PLC (35); however, the effector molecules responding to stretch (i.e. the mechanotransducers) are poorly understood. A force/pressure-sensing system in contractile (36,37) and also noncontractile (38,39) cells is mediated through stretch-induced changes in the interactions between transmembrane integrins, their extracellular matrix ligands, and their intercellular cytoskeletal ligands (40).

Stretch not only initiates contractile activity, but also modifies contractile responses in the heart through "mechanoelectrical feedback" (41). However, the role of mechanoelectrical feedback in the regulation of myometrial contractility has not been studied.

Increased shear force increases human vascular endothelial cell expression of cyclooxygenase-2, superoxide dismutase, and endothelial constitutive NOS genes (42) as well as endothelial cell NO production, NOS activity, and endothelial constitutive NOS mRNA and protein expression in ovine pulmonary artery (43). Whether or not the increasing myometrial stretch that occurs with advancing gestation has an equivalent effect on myometrial NO synthesis, thereby increasing the quiescent potential, is unknown.

Stretch and Hypertrophy

The hypertrophy of uterine myocytes is one of the earliest responses to ovarian hormones and likely modifies the cellular responses to stretch and pressure through effects on electrical activity (via ion channels) and membrane-cytoskeletal interactions. Current studies of the influence of cellular swelling on signaling are focused on the effects of ischemia and reperfusion on myocardial cells (44), but may lead to concepts from which we can extrapolate increased understanding of myometrial smooth muscle cells. For example, a defect in the coupling of intracellular Ca2+ sparks emitted by the SR RyRs and sarcolemmal VOCs is implicated in the pathophysiology of myocardial dysfunction in hypertension-induced myocardial hypertrophy and congestive heart failure (45). The data suggest that hypertrophy may alter the spatial orientation between the VOCs and the SR RyRs such that sparks (see above) couple inefficiently to VOC activation, thereby reducing the Ca2+ available for excitation-contraction coupling-in effect reducing the VOC recruitment by the sparks. The response of the pregnant myometrium to stretch-induced activation is likely to be markedly attenuated before term. The myometrium could provide a model for understanding how hypertrophy affects cellular signaling, and vice versa.

COORDINATION OF CONTRACTILE ACTIVITY

Coordination of contractions among cells is achieved by coupling responses of individual muscle cells to their neighbors. Coupling between cells is achieved chemically and/or electrically. Chemical coupling is the process whereby a chemical (excitatory or inhibitory) has access to multiple cells in a region, and may affect all cells having receptors. For example, norepinephrine release by sympathetic nerves may initiate contraction of a sufficient number of cells to allow propagation of action potentials, via electrical conductance. Electrical coupling is the process whereby low resistance bridges physically connect individual cells and enable the transfer of electrical signals (carried by ions or second messengers) from one cell to its neighbors. The so-called "gap junctional" protein subunits, "connexins," arrayed in multimeric structures called connexons [reviewed in Beyer (46) and Finbow and Pitts (47)] are considered to provide these low resistance bridges between cells in the heart and in smooth muscles, and also in nonmuscular cells in a variety of tissues.

Gap Junctions

Gap junction distribution is not necessarily homogenous in tissues (48), and the relation between junctional patterns and intercellular communication remains poorly understood. Also, the junctions are not necessarily composed of a single type of connexin (49), suggesting that the functional aspects of the junctions may be related to the heterogeneity of subunit composition.

One of the best studied gap-junctional subunits is C43, a 43-kD protein expressed in myocardium and myometrium as well as other cells. The biophysics of electrical conduction along specialized pathways characterized by cells that express C43 in distinctive patterns is of special interest in the myocardium. Directional flow of electrical excitation from the sinoatrial node is achieved through a discontinuous rather than a continuous expression of C43 in cells along the conduction path, with sinoatrial nodal, C43-negative cells alternating with C43-expressing atrial myocytes (50). Expression patterns of myocardial junctional proteins illustrate important aspects of their function, and that these patterns are not necessarily intuitive. Clearly, much remains to be learned about how arrays of connexons dictate their varied functions, particularly as applied to the myometrium.

Gap-junction dynamics. The dynamics of myometrial gap junctions show patterns of regulation that suggest a role in facilitating the process of parturition. However, the spatial pattern of C43 expression among uterine myocytes has not been explored extensively. Ultrastructural studies in rodents reveal that gap-junctional surface area increases immediately before term, reaching a maximum at the onset of labor, then declining rapidly (51,52). In the human uterus, the increase is more gradual throughout gestation. The gap-junctional area is increased by estrogen and decreased by progesterone. The expression of myometrial C43 is estrogen-dependent, although only partial sequences of the canonical estrogen response element have been identified in the C43 promoter region (53), suggesting a role for other elements, in particular the activator protein 1 element (54). Estrogen increases C43 expression in rat myometrium, an action opposed by progesterone treatment (55). Estrogen increases expression more in circular than in longitudinal muscle, and C43 expression is unevenly distributed in the circular muscle, forming patchy areas of high expression. At parturition, however, C43 expression is evenly distributed and present in both muscle layers of the rat uterus (55,56), suggesting that widespread myometrial expression of C43 is important to parturition.

PGs also increase C43 expression, and may underlie the preterm increase in C43 expression in human myometrium (57). Despite a major increase in C43 protein and assembled gap junctions, the level of C43 mRNA has been found either not to change or to increase up to 5-fold in rodent uteri at term (52,58), suggesting that junctional assembly is the more critically timed process in gap junction dynamics.

Recently, an additional 45-kD subunit of connexin was demonstrated in rat myometrium. The 45-kD connexin expression was found to be at a similar level in the nonpregnant and pregnant uterus, to decrease just before term, and then to increase in the postpartum period (58).

Gap-junctional transmission. In addition to the presence of formed gap junctions, the function (i.e. permeability) of these connections also can be regulated, although the mechanism responsible for this is not known. Recently, physiologic regulation of conductance in vivo was demonstrated by the finding that electrical conductance between rat myometrial cells was increased in animals laboring at term compared with preterm or postpartum uteri (59). However, C43 assembly into multimeric complexes (connexons) is currently the best documented mechanism for controlling gap-junctional coupling between myometrial smooth muscle cells.

Myometrial gap junctions are lower in number before term, increase by late in gestation, and are fully formed before the onset of labor. However, whether gap junctions are critical to the parturition process, facilitative, or merely correlative is not known. Perhaps chemical coupling-achieved through an enormous increase in the local concentration of excitatory autacoids (e.g., OT and prostaglandins)-is sufficient to ensure adequate coordination of contractility for delivery. Of note, elimination of C43 expression in the heart (see above) disrupts key conduction pathways, producing impaired function, but the myocardium still contracts. This suggests that intercellular coupling does not depend solely on C43, and hence may be primarily enhanced by, rather than fundamentally dependent on, gap junctional communication.

Coordination of Excitation

The three-dimensional spread of excitation has been explored through mathematical modeling in an attempt to understand how the wave of depolarization spreads, how the wave of Ca2+ mobilization is elicited by the electrical excitation, and how the wave spreads in the orderly manner required to achieve a coordinated, synchronized contraction. In one model, contractile waveforms arise primarily through action potential-based communication between cells via gap junctions (60). Also, waveforms were affected profoundly by the location of the initiating pacemaker cell. Although this model predicted waveforms resembling intrauterine pressure waves, transmission, based solely on action potentials, would be faster than actually observed. Another group (61) examined monolayers of human uterine myocytes to examine Ca2+ waves (see above) by confocal microscopy. The expected Ca2+ waves were found within the myocytes, could be elicited by OT treatment, and were independent of external Ca2+ concentration, all of which supports their emanation from intracellular Ca2+ stores. Waves of Ca2+ traveled from cell to cell in a coordinated fashion, propagating in a radial pattern from the initiating cell, demonstrating that coordination of response (i.e. coordinated oscillations in Ca2+ levels among cells) is an inherent property of myometrium. However, few cells contracted repetitively despite the continued presence of OT. Another model (62) may better explain the discrepancy between the speed of intercellular action potential spread (about 10 cm/s) and that of intercellular Ca2+ waves (about 4 µm/s); action potentials spread throughout muscle bundles to initiate contraction over a wide area, and initiate the slower Ca2+ waves that spread throughout the bundle. Each myocyte contracts for approximately 20 s before relaxing, in reasonable agreement with the value of 15 s predicted by the model. The predicted pressure wave closely approximated a genuine contraction event, and the largest myocyte bundle size allowed by the model was similar to that observed. The mechanism for the spread of intercellular Ca2+ waves, which was predicted to be nonelectrical because of the much slower speed of propagation when compared with the action potential, was examined in monolayers of human myocytes (62) and was a diffusible substance, the action of which was prevented by an inhibitor of cyclooxygenase, likely acting in a paracrine manner.

GESTATIONAL REGULATION OF UTERINE CONTRACTILITY AND OF RESPONSES TO SIGNALS

The Switch to Local and Humoral Control in Pregnancy

An intriguing characteristics of the pregnant uterus is the virtual disappearance of sympathetic, cholinergic, and peptidergic nerves (63,64) and also apparently NO-containing nerves (65). Such a change suggests that control of uterine contractility switches from autonomic to humoral-based. Indeed, the major endogenous contractile agonists of labor are generated locally: prostaglandins in the fetal chorion and maternal decidua, and OT in the decidua.

Gonadal Steroids Alter Membrane Potential

The hormonal milieu of pregnancy causes both hypertrophy of the uterine smooth muscle cells and, in some species, a hyperpolarization of the sarcolemma. Although estrogen alone can induce hypertrophy, both estrogen and progesterone cause hyperpolarization of the myometrial smooth muscle cell membrane (66). The mechanism of estrogen- and progesterone-mediated hyperpolarization is thought to be an increase in membrane permeability to K+, suggesting an effect on membrane ion channels (67). The hyperpolarization of the smooth muscle cell membrane reduces the excitability of the cells by electrical stimuli, by increasing the degree of depolarization required to elicit action potentials. Although there is evidence for a reduced membrane potential during gestation, this is not apparent in all species, suggesting that such a change is not critical to quiescence (67).

Pregnancy Alters Contractile Signaling

During gestation, the ability of the uterus to respond to activators of contraction is diminished (68) and reflects reduced concentrations of receptors. Thus contractile activators still can act, but the uterus normally remains quiescent. The synthesis of PGs by fetal chorion laeve normally is minimal before term (except perhaps in preterm labor associated with infection; see "Infection and labor," below), but increases markedly with labor (24). Interestingly, the umbilical cord is a major site of PGE2 production at term and contributes the bulk of the PGE2 present in amniotic fluid (69). However, there is no evidence that PGs can cross the fetal membrane in the absence of infection or rupture (70). Synthesis of OT within the uterus also is reduced before term and increases markedly at term to provide an autocrine mechanism for promoting contractions during labor.

The up-regulation of enzymes that degrade contractile agonists such as enkephalinase (which in human chorion laeve inactivates the potent contractile agonist endothelin-1), oxytocinase (degrades OT), and PGDH (degrades eicosanoids) will inhibit contraction; these are expressed at high levels during gestation (71,72). There is a significant decline in PGDH mRNA in chorion from spontaneously laboring women at term compared with those undergoing elective cesarean section (73). Women experiencing idiopathic (i.e. in the absence of infection) preterm labor also had a lower level of PGDH mRNA compared with term, elective section patients. Other investigators observed an increase in PGDH around the time of labor onset (70). Thus the fetal membranes have a high capacity to destroy endogenous contractile agonists during gestation, but it is not clear whether a decline in PGDH facilitates labor at term.

Expression of the key PG-synthesizing enzyme, cyclooxygenase-2, is low early in pregnancy, then becomes highly induced in the amnion near term in rats, sheep, and humans. In human amnion, one study estimated a ratio of 100:1 for cyclooxygenase-2 versus cyclooxygenase-1 mRNA (74). Thus, the availability of contractile agonists within the uterus may be maintained at a subthreshold level through reduced synthesis before term as well as by active catabolism.

Regulation of Ion Channels by Pregnancy

mRNA for VOC-type Ca2+ channels (measured by a polymerase chain reaction) increases before term, and also with antiprogesterone-induced preterm labor in the rat, but mRNA levels decline during labor (75).

Na+ channels (fast type) are present in myometrium, and their apparent concentration (inferred from current density) increases near term in rats (76). Also, a putative voltage-regulated Na+ channel, highly expressed in human heart and uterus (77), identified through molecular cloning analysis (78), has been localized to uterine nerves and myometrium in mice. In pregnancy, neuronal expression of this Na+ channel disappeared, whereas myometrial expression appeared, reaching a maximum at term; the Na+ channel co-localized with C43 (79). This regulatory pattern suggests a role in parturition, and the co-localization with C43 may indicate a functional role in junctional transmission (electrical coupling). An unusual voltage-gated K+ channel, noted above (30), also is regulated by pregnancy; it is expressed at higher levels at term in the mouse uterus, and this expression declines markedly after birth (80), suggesting a role in parturition.

Activation/Stimulation

Receptors for uterine stimulatory agonists. Many studies have documented low levels of OT receptors in myometrium and decidua before term and a marked increase just before (or during) labor. The receptors for OT, acetylcholine, norepinephrine, and ETs are members of the seven-transmembrane domain receptor structural family, which act via heterotrimeric Gqαβγ to activate PLCβ and to initiate the IP3-diacylglycerol signaling system (Fig. 4). PG receptors are members of the same G protein-coupled receptor family [reviewed in Coleman et al. (81)]. Molecular cloning studies have identified four distinct receptors for E-type PGs (8285), and one each for F type PG receptor, I-type (prostacyclin) (86), and D-type PGs. The E-type PG receptor 3 receptor family comprises a group of several subtypes resulting from alternative mRNA splicing (87), each of which couples to different effector pathways (88). Such diversity in signaling may explain conflicting observations of the biochemical response to prostanoids in the uterus. The presence of I-type PG (prostacyclin) receptors in the uterus has not yet been reported, although it should be noted that prostacyclin has efficacy at E-type PG receptor as well as I-type PG (prostacyclin) receptors.

Figure 4
figure4

Receptor-coupled, G-protein-mediated regulation of the IP3-diacylglycerol signaling mechanism of Ca2+ related smooth muscle activation. This scheme illustrates both the general pathway for distinct signaling via cAMP (on the left side) or PLC (right side) and also the possible mechanisms for signal modification ("cross-talk") via Gαi inhibition of adenylyl cyclase and cAMP-dependent protein kinase-mediated phosphorylation and inhibition of PLC. DAG, diacyl glycerol; PKA, protein kinase A; PKC, protein kinase C; PLC β2, phospholipase-Cβ2; PTX, pertussis toxin.

Receptor-coupled effectors and myometrial G proteins also are targets for regulation by estrogen and progesterone, and by pregnancy. Estrogen increases PLC activity in response to adrenergic, but not cholinergic, stimulation (89), and decreases the expression of Gs (90) in the rabbit uterus. With advancing gestation, Gs concentrations increase (91) in the human pregnant uterus, whereas in rat myometrium, the concentrations of Gi decrease and of Gq increase (92). These changes are consistent with the effects of pregnancy in promoting uterine quiescence through alterations in receptor-effector coupling.

Stimulatory agonists. ET, a potent stimulator of myometrial contractions, is synthesized by endometrial stromal cells. ET receptors have been localized to myocytes of the rat uterus (93), and estrogen treatment increases receptor concentration. ET-1 also is synthesized in the myometrium during the early postpartum period (94), suggesting a paracrine role for ET-1 in parturition, as for OT (see below). ET-1 binding increases in the myometrial membrane fraction of laboring rats (95). In the human uterus, responses to ET are mediated by the ETA receptor subtype (96). ET-1 has been localized in both the decidua and myometrium of the late pregnant human uterus, but not in the nonpregnant uterus (97). However, another study failed to detect ET-1 immunoreactivity in either term-pregnant or nonpregnant human myometrium (98). Both ETA and ETB receptors were found in human myometrium, but receptor levels were not affected by pregnancy (97). Potent efficacious contractile agonists such as ET and OT probably also contribute to the control of bleeding in the immediate postpartum period as well as facilitating labor.

Inhibitors of Contractility

Use of agents that inhibit uterine contractions has been the main strategy for the control of premature labor. Unfortunately, identification of highly effective, uterine-selective inhibitory agents remains elusive. The principal reasons are 3-fold. First, difficulties in accurately diagnosing preterm labor have hampered the identification of truly effective agents, making it hard to design clinical trials. Second, available agents do not have a high degree of uterine selectivity and are of limited use because of their effects on the myocardium and the vasculature, including those of the fetus. Third, the nature of gestation as a process characterized by highly redundant control mechanisms may require simultaneous inhibition of several components of systems for safe, prolonged inhibition of uterine contractions.

Endogenous inhibitors. Progesterone block. Although production of progesterone is important to the maintenance of gestation in sheep and rodents, the decline in progesterone production, which marks the end of gestation, cannot be detected in primates. Csapo's (99) progesterone block hypothesis for the mechanism of gestational quiescence, based on observations in rabbits, seems to be of paramount importance in all species except humans and nonhuman primates. Failure to observe these progesterone changes in humans has led to the concept that antagonism of progesterone response, rather than reduced production, overrides the progesterone block in humans at term. Transforming growth factor-β blocks the inductive effect of progesterone on in vitro expression of enkephalinase activity in human endometrial stromal cells (100). The relevance of this mechanism to parturition, if any, remains to be established. Considering all the available data, labor apparently ensues equally well in the presence and absence of progesterone [reviewed in Olson et al. (101)].

Karalis et al. (102) suggested that cortisol may be a physiologic antagonist of progesterone action. CRH concentrations (derived from placental trophoblasts) in maternal plasma increase exponentially during gestation, reaching a maximum at term. CRH itself (103) may determine the timing of parturition, because CRH concentrations rise more rapidly in women whose pregnancies resulted in spontaneous preterm labor than in those delivering postterm, and cortisol production is increased only slightly in pregnancy. Inducible NOS expression is down-regulated by glucocorticoids; thus the putative quiescing role of endogenous NO could be associated with the CRH regulatory mechanism. The importance of CRH in human parturition needs clarification.

Receptors and signaling processes. Fetal membranes composed of amnion-chorion and attached decidua produce a substance that inhibits VOC-type Ca2+ channel activity (104). Fetal membranes also inhibit contractions induced by prostaglandins but not by OT, suggesting an unusual type of agonist-selectivity for this effect (105). OT receptor coupling to PLC-β activation is inhibited by cAMP-dependent protein kinase-mediated phosphorylation (Fig. 4), although the target of the kinase (e.g. PLC, Gq, Gi, or receptor) was not identified (106). This "cross-talk" between opposing receptor systems has been confirmed in a reconstituted cellular system, as well as with HL60 cells, where agonist (chemotactic peptide) activation of the β2 isoform of PLC was inhibited by cAMP-dependent protein kinase-catalyzed phosphorylation of its serine residues (107). The inhibition was found to be mediated via Giβγ subunits, which are released from G upon agonist activation of the receptor [for a general review, see Neer (108)]; inhibition does not occur through the Gq-coupled PLC-activating receptors. These findings suggest that the observed pertussis toxin sensitivity of the rat myometrial PLC response to OT (106,109) may be explained by Gi protein acting via this cAMP-dependent mechanism to inhibit OT response. Such cross-talk between receptor systems (Fig. 4) clearly has the potential to account for the mechanism of such enigmatic phenomena as the cAMP-mediated "relaxation" of smooth muscle. Rigorous testing of this concept is warranted.

Nitric oxide. Uterine NO production is increased during pregnancy but declines markedly at term, and this NO production is difficult to detect in the nonpregnant uterus (reviewed in Sladek et al. (110)). Expression of inducible NOS is localized to myometrial smooth muscle cells and decidual epithelium of the pregnant rat (65). Although all three isoforms of NOS are found in the uterus under different conditions, only inducible NOS expression follows a pattern compatible with a role in uterine quiescence. Expression of inducible NOS in human myometrium falls markedly with term or preterm labor (111), suggesting that NO may be an important component of the endogenous system that maintains uterine quiescence before term. Augmentation of these signaling mechanisms may offer innovative approaches to tocolysis, although this needs to be rigorously confirmed, and the safety to both mother and fetus, must be demonstrated clearly.

Although cellular sources are unknown, all three NOS isoforms are expressed in the cervix. Cervical inducible NOS is up-regulated in laboring rats (112), suggesting a role in the increased cervical distensibility required for parturition. Comparing d 19 with term, the greatest change was in inducible NOS expression, which, however, increased by less than 10%. The physiologic relevance of this modest change remains unclear.

Exogenous inhibitors (tocolytic agents). One clinical approach to inhibiting uterine contractions in preterm labor has been to use tocolytic agents such as nifedipine that reduce intracellular Ca2+ ion concentrations by inhibiting VOC-type Ca2+ channels. However, these agents lack uterine selectivity and produce cardiovascular side effects, such as reduction in uterine and umbilical blood flow (113). β-Adrenoreceptor agonists (e.g. ritodrine and terbutaline) reduce intracellular Ca2+ ion concentration via the cAMP signaling cascade. These agents are important, but are limited by the development of maternal pulmonary edema and marked tachyphylaxis through β-adrenoreceptor down-regulation (113). Although cAMP also may effect relaxation by reducing the sensitivity of MLC kinase to Ca2+, this mechanism has not been proven. Magnesium sulfate acts by inhibiting Ca2+ influx, probably by interaction with the cytoplasmic face of VOC-type Ca2+ channels (114).

Other tocolytic strategies have been to use receptor antagonists to block OT or PGF. Although theoretically sound, these approaches have had limited success. High endogenous agonist concentrations may limit the efficacy of competitive OT antagonists. In a random, double-blind clinical trial in 112 women experiencing preterm labor, one such agonist, atosiban, reduced contraction frequency about 2-fold greater than did placebo (115). More recently, a nonrandomized study of 62 patients demonstrated a 70% success rate for delay of delivery by more that 48 h, an effect equivalent to that of ritodrine, but with fewer side effects (116). Although a 48-h delay in parturition may not seem to be of obvious importance to a fetus that is born months prematurely, it is, in fact, critical to survival. Even a 24-h delay in delivery permits the administration of lung-maturing glucocorticoids such as betamethasone, which switch on surfactant production and secretion by alveolar type II cells. Although outside the scope of this review, surfactant is critically important in providing sufficient alveolar surface tension to facilitate alveolar air sac expansion so that gas exchange can occur and respiratory distress syndrome be prevented. Thus, any delay in parturition provides a window of opportunity to prepare the lungs for their role as a gas-exchange organ after delivery, and is fundamental to the survival of premature infants (117).

Suppression of prostaglandin production using nonsteroidal anti-inflammatory drugs such as indomethacin must be controlled carefully, especially the duration of use (113), to prevent side effects such as prenatal constriction of the ductus arteriosus, the patency of which is maintained by PGE2 (118). The inducible isoform of PG synthetase H, or cyclooxygenase-2, is largely responsible for the increase in PG production at term (119,120). Cyclooxygenase-2-specific inhibitors could be effective tocolytic agents and be free of adverse effects on the ductus arteriosus and other fetal organs.

A possible approach to tocolysis is by manipulation of the NO signaling pathway in the myometrium. NO is the active chemical agent mediating the effects of smooth muscle relaxants such as the nitroso vasodilators (e.g. nitroglycerine). Thus nitroglycerine or a similar NO donor eventually may prove to be another possible tocolytic agent. Likewise, inhibition of cGMP breakdown, by a specific cGMP phosphodiesterase inhibitor, may reduce uterine contractility.

Specific inhibitors of ATP-sensitive K+ channels and activators are available; however, their use as tocolytic agents is not especially promising because their inhibitory action on the pregnant myometrium is partial at best (15). Agents that activate KCa channels, such as a recently characterized African herbal glycoside, dehydrosoyasaponin I (121), offer some tocolytic potential but lack uterine specificity, which may limit their clinical use.

Prepartal Gestational Regulation

Activation/normal labor. Signaling and parturition: Conversion from quiescence to activation. The approach and onset of labor at term involves changes in many components of the contractile signaling system. Local production of contractile agonists increases, and structural alterations of the cytoarchitecture increase the effectiveness of endogenous agonists. Despite decades of study, the mechanisms that signal the onset of active labor in humans remain incompletely understood.

Alterations in myometrial structure and functional regulation at term. A major change in the ability of myometrial cells to communicate with neighboring cells is the increased synthesis of the gap-junctional proteins, C43 in particular, late in gestation. Closer to term, the gap-junctional proteins are assembled into connexons, which form the gap-junctions. The increased electrical coupling between adjacent cells facilitates the coordination of myometrial excitation, allowing the contraction to develop propulsive force. However, it has not been established that connexons are necessary for coordination of contractions.

OT receptors in both myometrial and decidual cells are markedly up-regulated just before the onset of labor. The dynamics of the recently cloned human OT receptor during gestation have been described. OT receptor protein is present in the nonpregnant myometrium at reduced levels, which increase nearly 300-fold (mRNA levels) at parturition (122). The receptors are distributed unevenly throughout the myometrium, rather than being homogeneously expressed from cell to cell. Decidual OT receptors are thought to couple OT to PG production in a paracrine amplification mechanism to enhance the contractile action of OT on the myometrium. In contrast to posterior pituitary OT, which is unchanged, local production of OT in the amnion, chorion, and decidua (123,124) increases markedly at term; this may serve as a paracrine mechanism for OT stimulation of contractions [reviewed in Zingg et al. (125)]. Estrogen increases uterine OT production at term in both rat and human uterus (123,126,127).

It long has been argued that the estrogen:progesterone ratio governs uterine excitability throughout gestation, and that an increase in this ratio underlies activation of the uterus at term. The ratio could be increased by increasing estrogen production without changing progesterone. The fetal adrenal steroid, DHEAS, which can be converted to estrogen by placental enzymes, may be involved in such a regulatory mechanism whereby placental estrogen feedback inhibits fetal adrenal DHEAS production (101). Late in gestation, this inhibition may be lost, leading to increased DHEAS and maternal estrogen production, as seen at term. The increased estrogen could overcome the suppressive effect of progesterone on OT receptor expression as well as increase OT and prostaglandin production, all of which promote uterine activation and labor. However, although DHEAS administration to the primate fetus does increase maternal estrogen production and uterine contractility, maternal administration of exogenous estrogen does not alter contractility. Thus, the role of DHEAS may involve a complex fetal-placental interaction involving other, as yet un-identified mediators.

ET concentrations in human amniotic fluid are higher at mid-trimester than at term (128) leaving open the question of a role for fetal membrane-derived ET in the labor process (and also the significance of enkephalinase). PG production by both the uterine decidua in rat (119) and fetal chorion laeve is increased at term, providing a source of contractile PGs. However, PGs or ET released into the amniotic compartment may not reach the myometrium until membrane rupture.

Lessons from Knockouts

Gene deletion ("knockout") is one approach to analyzing the putative role of biologic signals. Genes for several prominent signaling molecules have been deleted, but the only reported putative uterine inhibitory-related deletion is the gene for inducible NOS. Deleting this gene had no apparent effect on gestation or parturition (129131), despite differences in the phenotype produced [reviewed in Cobb and Danner (132)]. Genes for other putative stimulatory signals, the OT receptor (133), cyclooxygenase-1 (134), and cyclooxygenase-2 (135), also have been deleted, again with no apparent effect on gestation or parturition. The cyclooxygenase-2 knockout in mice did lead to inhibition of ovulation.

Deletion of the C43 gene produced an atrioventricular conduction block, which prevented the increased cardiac output needed to sustain oxygenation and perfusion and survival (136). Disruption of the progesterone receptor gene causes infertility and inability to support implantation; therefore, gestational changes cannot be studied in these mice (137). Prolactin receptor gene deletion also prevented implantation TBASE, ID: 4223; no published report yet). Rat and human myometrium and endometrium contain binding sites for epidermal growth factor; estrogen increases epidermal growth factor receptor levels (13). Deletion of the estrogen receptor gene also produced infertility, but the mice were otherwise grossly normal (138). Of note, the estrogen receptor gene knockout mice had no uterotrophic response (progesterone receptor induction) to epidermal growth factor (139).

Estrogen receptor gene overexpression, on the other hand, produced delayed parturition and prolonged labor (140). A second molecular form of the estrogen receptor (designated estrogen receptor β) is expressed in the uterus, complicating interpretation of the estrogen receptor α knockout phenotype (141).

During gestation and parturition, uterine activity clearly is controlled by a complex network of redundant controls so that eliminating a single component may not be sufficient to derail the mechanism. The implication of this interpretation is that strategic targeting of multiple genes may be required to perturb the gestational mechanisms sufficiently to gain insight into the regulatory interactions.

Infection and Labor

Considerable attention has been paid to the role of infection and consequent inflammation of the uterine decidua and fetal membranes in the etiology of preterm labor. Indeed, intrauterine infection and the ensuing production of inflammatory mediators (cytokines and growth factors) have been documented in preterm labor associated with premature rupture of the membranes. The inflammatory mediators IL-1β and tumor necrosis factor-α cause up-regulation of cyclooxygenase-2 in rat endometrial cell lines (119), consistent with the enhanced prostaglandin production by the infected uterus. The intensity with which intrauterine infection stimulates delivery has led to speculation that all labor is the result of an infection-like process. However, the initiator of this process has not been determined because most labor is associated with the absence of detectable infection.

An understanding of timing mechanisms could shed light on the changes inherent to premature labor, and thereby suggest better tocolytic therapies. Of concern is the ability to sort out the contribution of inflammatory mediators to normal and premature labor to understand the most enigmatic problem of noninfection, "idiopathic" preterm labor, which may account for the bulk of premature births for which tocolytic intervention could be of medical value (i.e., not complicated by prematurely ruptured membranes) (113). If normal labor is not due to bacterial infection, then perhaps the hormonal changes that lead to alterations in cytokine and growth factor production at term need only be sought, which narrows the targets considerably. Alternatively, it can be argued that, in normal labor, there is a loss of resistance to infection-related signaling molecules (e.g., cytokines), which is maintained throughout most of gestation.

The predictive value of intrauterine infection on premature delivery has been the subject of several recent multicenter clinical studies (142145). Although the studies confirm that elevated amniotic fluid IL-6 levels (144) are an indicator of an early state of intrauterine infection and the presence of bacterial vaginosis is associated with an increased risk of spontaneous preterm birth, elevation of cervicovaginal fetal fibronectin levels, a short cervix, and previous preterm birth were found (145) to be stronger predictors of preterm birth. Earlier studies demonstrated that bacterial vaginosis is associated with elevated fetal fibronectin levels (146). Thus, at present, elevated cervical fetal fibronectin levels appear to be one of the strongest predictors of premature birth and are closely associated with the presence of intrauterine infection.

SUMMARY

This review has focused largely on subcellular events that govern smooth muscle contraction and relaxation, using the recognized physiologic and biochemical changes in the myometrium during pregnancy and gestation as a unifying theme to illustrate the relevance of the regulatory phenomena. Thus, we have discussed roles of small GTP binding proteins, ion channels, and "sparks," and integrin-cytoskeletal interactions in cells other than myometrium and even nonmuscle cells to illustrate their potential for affecting myometrial function. It is often the case that advances in other fields provide insight into mechanisms that subsequently are found to be relevant to the myometrium (a good example is MLC kinase in the regulation of tracheal smooth muscle contractility). We believe that the advances in what appear to be distantly related disciplines will serve as guiding principles in the quest for better understanding uterine function; only further experimentation will determine whether we are correct. The role of stretch as a signaling mechanism for both uterine quiescence and labor is a particularly exciting prospect for research, which is likely to provide important insight into uterine function. If any of the topics in this review spark a new research interest in the reader, then we will have fulfilled our goal.

Abbreviations

C43:

connexin 43

CRH:

corticotrophin-releasing hormone

DHEAS:

dehydroepiandrosterone sulfate

EP1-4:

E-type prostaglandin receptors 1-4

ET:

endothelin

Gs, Gq:

G proteins sq

IP3:

inositol 1,4,5-triphosphate

IP3R:

inositol 1,4,5-triphosphate receptor

KCa:

high conductance Ca2+-activated K+ channel

MLC:

myosin light chain

MLC-P:

myosin light chain phosphatase

NO:

nitric oxide

NOS:

nitric oxide synthase

OT:

oxytocin

PG:

prostaglandin

PGDH:

prostaglandin dehydrogenase

PLC:

phospholipase C

Ras:

small GTP-binding protein of 21 Ras superfamily

Rac-1:

Rho

RhoA:

subfamily members of Ras superfamily

RyR:

ryanodine receptor, ryanodine-sensitive intracellular

Ca2+:

channel

SR:

sarcoplasmic reticulum

VOC:

voltage-operated Ca2+ channels

References

  1. 1

    Bulbring E, Tomita T 1987 Catecholamine action on smooth muscle. Pharmacol Rev 39: 49–96

    CAS  PubMed  Google Scholar 

  2. 2

    Parkington HC, Harding R, Sigger JN 1988 Co-ordination of electrical activity in the myometrium of pregnant ewes. J Reprod Fertil 82: 697–705

    CAS  PubMed  Google Scholar 

  3. 3

    Lammers WJEP, Arafat K, el-Kays A, el-Sharkawy TY 1994 Spatial and temporal variations in local spike propagation in the myometrium of the 17-day pregnant rat. Am J Physiol 267: C1210–C1223

    CAS  PubMed  Google Scholar 

  4. 4

    Lammers WJ, Ahmad HR, Arafat K 1996 Spatial and temporal variations in pacemaking and conduction in the isolated renal pelvis. Am J Physiol 270: F567–F574

    CAS  PubMed  Google Scholar 

  5. 5

    Word RA 1995 Myosin phosphorylation and the control of myometrial contraction/relaxation. Semin Perinatol 19: 3–14

    CAS  PubMed  Google Scholar 

  6. 6

    Horowitz A, Menice CB, Laporte R, Morgan KG 1996 Mechanisms of smooth muscle contraction. Physiol Rev 76: 967–1003

    CAS  PubMed  PubMed Central  Google Scholar 

  7. 7

    Bárány K, Bárány M 1990 Myosin light chain phosphorylation in uterine smooth muscle. In: Carsten ME, Miller JD (eds) Uterine Functions: Molecular and Cellular Aspects. Plenum Press, New York, 71–98.

    Google Scholar 

  8. 8

    Kimura K, Ito M, Amano M, Chihara K, Fukata Y, Nakafuku M, Yamamori B, Feng J, Nakano T, Okawa K, Iwamatsu A, Kaibuchi K 1996 Regulation of myosin phosphatase by Rho and Rho-associated kinase (Rho-kinase). Science 273: 245–248

    CAS  PubMed  PubMed Central  Google Scholar 

  9. 9

    Tapon N, Hall A 1997 Rho, Rac and Cdc42 GTPases regulate the organization of the actin cytoskeleton. Curr Opin Cell Biol 9: 86–92

    CAS  PubMed  Google Scholar 

  10. 10

    Ruzycky AL 1997 Pregnancy increases the expression of cytoskeletal signaling GTPases, rac-1 and RhoA, in human uterine myocytes. J Soc Gynecol Invest 4( Suppl): 162( abstr)

    Google Scholar 

  11. 11

    Ruzycky AL 1997 Agonist-specific changes in actin filament polymerization are associated with increased cytoskeletal signaling in the rat myometrium. J Soc Gynecol Invest 4( suppl): 106A( abstr)

    Google Scholar 

  12. 12

    Wray S 1993 Uterine contraction and physiological mechanisms of modulation. Am J Physiol 264: C1–C18

    CAS  PubMed  Google Scholar 

  13. 13

    Fuchs AR 1995 Plasma, membrane receptors regulating myometrial contractility and their hormonal modulation. Semin Perinatol 19: 15–30

    CAS  PubMed  Google Scholar 

  14. 14

    Szal SE, Repke JT, Seely EW, Graves SW, Parker CA, Morgan KG 1994 [Ca2+]i signaling in pregnant human myometrium. Am J Physiol 267: E77–E87

    CAS  PubMed  Google Scholar 

  15. 15

    Sanborn BM 1995 Ion channels and the control of myometrial electrical activity. Semin Perinatol 19: 31–40

    CAS  PubMed  Google Scholar 

  16. 16

    Butler A, Tsunoda S, McCobb DP, Wei A, Salkoff L 1993 mSlo, a complex mouse gene encoding "maxi" calcium-activated potassium channels. Science 261: 221–224

    CAS  PubMed  Google Scholar 

  17. 17

    Bootman MD, Berridge MJ 1995 The elemental principles of calcium signaling. Cell 83: 675–678

    CAS  PubMed  Google Scholar 

  18. 18

    Berridge MJ 1997 Elementary and global aspects of calcium signaling-annual review prize lecture. J Physiol 499: 291–306

    CAS  PubMed  PubMed Central  Google Scholar 

  19. 19

    Yue DT 1997 Quenching the spark in the heart. Science 276: 755–756

    CAS  PubMed  Google Scholar 

  20. 20

    Nelson MT, Cheng H, Rubart M, Santana LF, Bonev AD, Knot HJ, Lederer WJ 1995 Relaxation of arterial smooth muscle by calcium sparks. Science 270: 633–637

    CAS  PubMed  Google Scholar 

  21. 21

    Lynn S, Morgan JM, Lamb HK, Meissner G, Gillespie JI 1995 Isolation and partial cloning of ryanodine-sensitive Ca2+ release channel protein isoforms from human myometrial smooth muscle. FEBS Lett 372: 6–12

    CAS  PubMed  Google Scholar 

  22. 22

    Gebremedhin D, Kaldunski M, Jacobs ER, Harder DR, Roman RJ 1996 Coexistence of two types of Ca2+-activated K+ channels in rat renal arterioles. Am J Physiol 270: F69–F81

    CAS  PubMed  Google Scholar 

  23. 23

    Anwer K, Oberti C, Perez GJ, Perez-Reyes N, McDougall JK, Monga M, Sanborn BM, Stefani E, Toro L 1993 Calcium-activated K+ channels as modulators of human myometrial contractile activity. Am J Physiol 265: C976–C985

    CAS  PubMed  Google Scholar 

  24. 24

    MacDonald PC, Casey ML 1993 The accumulation of prostaglandins (PG) in amniotic fluid is an aftereffect of labor and not indicative of a role for PGE2 or PGF2 alpha in the initiation of human parturition. J Clin Endocrinol Metab 76: 1332–1339

    CAS  PubMed  Google Scholar 

  25. 25

    Meera P, Anwer K, Monga M, Oberti C, Stefani E, Toro L, Sanborn BM 1995 Relaxin stimulates myometrial calcium-activated potassium channel activity via protein kinase A. Am J Physiol 269: C312–C317

    CAS  PubMed  Google Scholar 

  26. 26

    Hamaguchi M, Ishibashi T, Imai S 1992 Involvement of charybdotoxin-sensitive K+ channel in the relaxation of bovine tracheal smooth muscle by glyceryl trinitrate and sodium nitroprusside. J Pharmacol Exp Ther 262: 263–270

    CAS  PubMed  Google Scholar 

  27. 27

    Bolotina VM, Najibi S, Palacino JJ, Pagano PJ, Cohen RA 1994 Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle. Nature 368: 850–853

    CAS  PubMed  PubMed Central  Google Scholar 

  28. 28

    Dworetzky SI, Trojnacki JT, Gribkoff VK 1994 Cloning and expression of a human large-conductance calcium-activated potassium channel. Brain Res Mol Brain Res 27: 189–193

    CAS  PubMed  Google Scholar 

  29. 29

    Khan RN, Smith SK, Morrison JJ, Ashford ML 1993 Properties of large-conductance K+ channels in human myometrium during pregnancy and labour. Proc R Soc Lond B Biol Sci 251: 9–15

    CAS  Google Scholar 

  30. 30

    Folander K, Smith JS, Antanavage J, Bennett C, Stein RB, Swanson R 1990 Cloning and expression of the delayed-rectifier IsK channel from neonatal rat heart and diethylstilbestrol-primed rat uterus. Proc Natl Acad Sci USA 87: 2975–2979

    CAS  PubMed  Google Scholar 

  31. 31

    Kasai Y, Tsutsumi O, Taketani Y, Endo M, Iino M 1995 Stretch-induced enhancement of contractions in uterine smooth muscle of rats. J Physiol 486: 373–384

    CAS  PubMed  PubMed Central  Google Scholar 

  32. 32

    Crozatier B 1996 Stretch-induced modifications of myocardial performance: from ventricular function to cellular and molecular mechanisms. Cardiovasc Res 32: 25–37

    CAS  PubMed  Google Scholar 

  33. 33

    Arai A, Kodama I, Toyama J 1996 Roles of Cl- channels and Ca2+ mobilization in stretch-induced increase of SA node pacemaker activity. Am J Physiol 270: H1726–H1735

    CAS  PubMed  Google Scholar 

  34. 34

    Hansen DE, Stacy GP J, Taylor LK, Jobe RL, Wang Z, Denton PK, Alexander J Jr 1995 Calcium- and sodium-dependent modulation of stretch-induced arrhythmias in isolated canine ventricles. Am J Physiol 268: H1803–H1813

    CAS  PubMed  Google Scholar 

  35. 35

    Nakayama K, Tanaka Y 1993 Stretch-induced contraction and Ca2+ mobilization in vascular smooth muscle. Biol Signals 2: 241–252

    CAS  PubMed  Google Scholar 

  36. 36

    Wilson E, Sudhir K, Ives HE 1995 Mechanical strain of rat vascular smooth muscle cells is sensed by specific extracellular matrix/integrin interactions. J Clin Invest 96: 2364–2372

    CAS  PubMed  PubMed Central  Google Scholar 

  37. 37

    Bloom S, Lockard VG, Bloom M 1996 Intermediate filament-mediated stretch-induced changes in chromatin: a hypothesis for growth initiation in cardiac myocytes. J Mol Cell Cardiol 28: 2123–2127

    CAS  PubMed  Google Scholar 

  38. 38

    Pommerenke H, Schreiber E, Durr F, Nebe B, Hahnel C, Moller W, Rychly J 1996 Stimulation of integrin receptors using a magnetic drag force device induces an intracellular free calcium response. Eur J Cell Biol 70: 157–164

    CAS  PubMed  Google Scholar 

  39. 39

    Wright M, Jobanputra P, Bavington C, Salter DM, Nuki G 1996 Effects of intermittent pressure-induced strain on the electrophysiology of cultured human chondrocytes: evidence for the presence of stretch-activated membrane ion channels. Clin Sci 90: 61–71

    CAS  PubMed  Google Scholar 

  40. 40

    Ingber D 1991 Integrins as mechanochemical transducers. Curr Opin Cell Biol 3: 841–848

    CAS  PubMed  Google Scholar 

  41. 41

    Lab MJ 1996 Mechanoelectric feedback (transduction) in heart: concepts and implications. Cardiovasc Res 32: 3–14

    CAS  PubMed  Google Scholar 

  42. 42

    Topper JN, Cai J, Falb D, Gimbrone MA Jr 1996 Identification of vascular endothelial genes differentially responsive to fluid mechanical stimuli: cyclooxygenase-2, manganese superoxide dismutase, and endothelial cell nitric oxide synthase are selectively up-regulated by steady laminar shear stress. Proc Natl Acad Sci USA 93: 10417–10422

    CAS  PubMed  Google Scholar 

  43. 43

    Black SM, Johengen M, Bristow J, Soifer SJ 1996 Ventilation and oxygenation induce endothelial nitric oxide synthase gene expression in the lungs of fetal lambs. Pediatr Res 39: 326A( abstr)

    Google Scholar 

  44. 44

    Vandenberg JI, Rees SA, Wright AR, Powell T 1996 Cell swelling and ion transport pathways in cardiac myocytes. Cardiovasc Res 32: 85–97

    CAS  PubMed  Google Scholar 

  45. 45

    Gomez AM, Valdivia HH, Cheng H, Lederer MR, Santana LF, Cannell MB, McCune SA, Altschuld RA, Lederer WJ 1997 Defective excitation-contraction coupling in experimental cardiac hypertrophy and heart failure. Science 276: 800–806

    CAS  PubMed  Google Scholar 

  46. 46

    Beyer EC 1993 Gap junctions. Int Rev Cytol 137C: 1: 37

    Google Scholar 

  47. 47

    Finbow ME, Pitts JD 1993 Is the gap junction channel-the connexon-made of connexin or ductin? J Cell Sci 106: 463–471

    CAS  PubMed  Google Scholar 

  48. 48

    Hall JE, Gourdie RG 1995 Spatial organization of cardiac gap junctions can affect access resistance. Microsc Res Tech 31: 446–451

    CAS  PubMed  Google Scholar 

  49. 49

    Risek B, Klier FG, Phillips A, Hahn DW, Gilula NB 1995 Gap junction regulation in the uterus and ovaries of immature rats by estrogen and progesterone. J Cell Sci 108: 1017–1032

    CAS  PubMed  Google Scholar 

  50. 50

    ten Velde I, de Jonge B, Verheijck EE, van Kempen MJ, Analbers L, Gros D, Jongsma HJ 1995 Spatial distribution of connexin 43, the major cardiac gap junction protein, visualizes the cellular network for impulse propagation from sinoatrial node to atrium. Circ Res 76: 802–811

    CAS  PubMed  Google Scholar 

  51. 51

    Garfield RE (ed) 1990 Uterine Contractility: Mechanisms of Control. Serono Symposia, USA, Norwell, MA

    Google Scholar 

  52. 52

    Garfield RE, Ali M, Yallampalli C, Izumi H 1995 Role of gap junctions and nitric oxide in control of myometrial contractility. Semin Perinatol 19: 41–51

    CAS  PubMed  Google Scholar 

  53. 53

    Chen ZQ, Lefebvre D, Bai XH, Reaume A, Rossant J, Lye SJ 1995 Identification of two regulatory elements within the promoter region of the mouse connexin 43 gene. J Biol Chem 270: 3863–3868

    CAS  PubMed  Google Scholar 

  54. 54

    Yu W, Dahl G, Werner R 1994 The connexin 43 gene is responsive to oestrogen. Proc R Soc Lond B Biol Sci 255: 125–132

    CAS  Google Scholar 

  55. 55

    Risek B, Guthrie S, Kumar N, Gilula NB 1990 Modulation of gap junction transcript and protein expression during pregnancy in the rat. J Cell Biol 110: 269–282

    CAS  PubMed  Google Scholar 

  56. 56

    Risek B, Gilula NB 1991 Spatiotemporal expression of three gap junction gene products involved in fetomaternal communication during rat pregnancy. Development 113: 165–181

    CAS  PubMed  Google Scholar 

  57. 57

    Chow L, Lye SJ 1994 Expression of the gap junction protein connexin-43 is increased in the human myometrium toward term and with the onset of labor. Am J Obstet Gynecol 170: 788–795

    CAS  PubMed  Google Scholar 

  58. 58

    Albrecht JL, Atal NS, Tadros PN, Orsino A, Lye SJ, Sadovsky Y, Beyer EC 1996 Rat uterine myometrium contains the gap junction protein connexin 45, which has a differing temporal expression pattern from connexin 43. Am J Obstet Gynecol 175: 853–858

    CAS  PubMed  Google Scholar 

  59. 59

    Miyoshi H, Boyle MB, MacKay LB, Garfield RE 1996 Voltage-clamp studies of gap junctions between uterine muscle cells during term and preterm labor. Biophys J 71: 1324–1334

    CAS  PubMed  PubMed Central  Google Scholar 

  60. 60

    Andersen HF, Barclay ML 1995 A computer model of uterine contractions based on discrete contractile elements. Obstet Gynecol 86: 108–111

    CAS  PubMed  Google Scholar 

  61. 61

    Young RC, Hession RO 1996 Intra-and intercellular calcium waves in cultured human myometrium. J Muscle Res Cell Motil 17: 349–355

    CAS  PubMed  Google Scholar 

  62. 62

    Young RC 1997 A computer model of uterine contractions based on action potential propagation and intercellular calcium waves. J Soc Gynecol Invest 4: 160A( abstr)

    Google Scholar 

  63. 63

    Stjernquist M, Sjöberg N-O 1994 Neurotransmitters in the myometrium. In: Chard T, Grudzinskas JG (eds) The Uterus. University Press, Cambridge, 193–229.

    Google Scholar 

  64. 64

    Sjoberg NO 1968 Considerations on the cause of disappearance of the adrenergic transmitter in uterine nerves during pregnancy. Acta Physiol Scand 72: 510–517

    CAS  PubMed  Google Scholar 

  65. 65

    Riemer RK, Buscher C, Bansal RK, Black SM, He Y, Natuzzi ES 1997 Increased expression of nitric oxide synthase in the myometrium of the pregnant rat uterus. Am J Physiol 272: E1008–E1015

    CAS  PubMed  Google Scholar 

  66. 66

    Kawarabayashi T 1994 Electrophysiology of the human myometrium. In: Chard T, Grudzinskas JG (eds) The Uterus. University Press, Cambridge, 148–172.

    Google Scholar 

  67. 67

    Parkington HC, Coleman HA 1990 The role of membrane potential in the control of uterine motility. In: Carsten ME, Miller JD (eds) Uterine Function. Plenum, New York, 195–248.

    Google Scholar 

  68. 68

    Riemer RK, Goldfien AC, Goldfien A, Roberts JM 1986 Rabbit uterine oxytocin receptors and in vitro contractile response: abrupt changes at term and the role of eicosanoids. Endocrinology 119: 699–709

    CAS  PubMed  Google Scholar 

  69. 69

    McCoshen JA, Tulloch HV, Johnson KA 1989 Umbilical cord is the major source of prostaglandin E2 in the gestational sac during term labor. Am J Obstet Gynecol 160: 973–978

    CAS  PubMed  Google Scholar 

  70. 70

    Mitchell BF, Rogers K, Wong S 1993 The dynamics of prostaglandin metabolism in human fetal membranes and decidua around the time of parturition. J Clin Endocrinol Metab 77: 759–764

    CAS  PubMed  Google Scholar 

  71. 71

    Germain AM, Smith J, Casey ML, MacDonald PC 1994 Human fetal membrane contribution to the prevention of parturition: uterotonin degradation. J Clin Endocrinol Metab 78: 463–70

    CAS  PubMed  Google Scholar 

  72. 72

    Mitchell BF, Wong S 1995 Metabolism of oxytocin in human decidua, chorion, and placenta. J Clin Endocrinol Metab 80: 2729–2733

    CAS  PubMed  Google Scholar 

  73. 73

    Sangha RK, Walton JC, Ensor CM, Tai HH, Challis JR 1994 Immunohistochemical localization, messenger ribonucleic acid abundance, and activity of 15-hydroxyprostaglandin dehydrogenase in placenta and fetal membranes during term and preterm labor. J Clin Endocrinol Metab 78: 982–989

    CAS  PubMed  Google Scholar 

  74. 74

    Slater D, Berger L, Newton R, Moore G, Bennett P 1994 The relative abundance of type 1 to type 2 cyclo-oxygenase mRNA in human amnion at term. Biochem Biophys Res Commun 198: 304–308

    CAS  PubMed  Google Scholar 

  75. 75

    Tezuka N, Ali M, Chwalisz K, Garfield RE 1995 Changes in transcripts encoding calcium channel subunits of rat myometrium during pregnancy. Am J Physiol 269: C1008–C1017

    CAS  PubMed  Google Scholar 

  76. 76

    Inoue Y, Sperelakis N 1991 Gestational change in Na+ and Ca2+ channel current densities in rat myometrial smooth muscle cells. Am J Physiol 260: C658–C663

    CAS  PubMed  Google Scholar 

  77. 77

    Felipe A, Knittle TJ, Doyle KL, Tamkun MM 1994 Primary structure and differential expression during development and pregnancy of a novel voltage-gated sodium channel in the mouse. J Biol Chem 269: 30125–30131

    CAS  PubMed  Google Scholar 

  78. 78

    George AL, Knittle TJ, Tamkun MM 1992 Molecular cloning of an atypical voltage-gated sodium channel expressed in human heart and uterus-evidence for a distinct gene family. Proc Natl Acad Sci USA 89: 4893–4897

    CAS  PubMed  Google Scholar 

  79. 79

    Knittle TJ, Doyle KL, Tamkun MM 1996 Immunolocalization of the mNav2.3 Na+ channel in mouse heart: upregulation in myometrium during pregnancy. Am J Physiol 270: C688–C696

    CAS  PubMed  Google Scholar 

  80. 80

    Felipe A, Knittle TJ, Doyle KL, Snyders DJ, Tamkun MM 1994 Differential expression of Isk mRNAs in mouse tissue during development and pregnancy. Am J Physiol 267: C700–C705

    CAS  PubMed  Google Scholar 

  81. 81

    Coleman RA, Smith WL, Narumiya S 1994 International Union of Pharmacology classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes. Pharmacol Rev 46: 205–229

    CAS  Google Scholar 

  82. 82

    Funk CD, Furci L, FitzGerald GA, Grygorczyk R, Rochette C, Bayne MA, Abramovitz M, Adam M, Metters KM 1993 Cloning and expression of a cDNA for the human prostaglandin E receptor EP1 subtype. J Biol Chem 268: 26767–26772

    CAS  PubMed  Google Scholar 

  83. 83

    Breyer RM, Davis LS, Nian C, Redha R, Stillman B, Jacobson HR, Breyer MD 1996 Cloning and expression of the rabbit prostaglandin EP4 receptor. Am J Physiol 270: F485–F493

    CAS  PubMed  Google Scholar 

  84. 84

    Sando T, Usui T, Tanaka I, Mori K, Sasaki Y, Fukuda Y, Namba T, Sugimoto Y, Ichikawa A, Narumiya S 1994 Molecular cloning and expression of rat prostaglandin E receptor EP2 subtype. Biochem Biophys Res Commun 200: 1329–1333

    CAS  PubMed  Google Scholar 

  85. 85

    An S, Yang J, Xia M, Goetzl EJ 1993 Cloning and expression of the EP2 subtype of human receptors for prostaglandin E2 . Biochem Biophys Res Commun 197: 263–270

    CAS  PubMed  Google Scholar 

  86. 86

    Oida H, Namba T, Sugimoto Y, Ushikubi F, Ohishi H, Ichikawa A, Narumiya S 1995 In situ hybridization studies of prostacyclin receptor mRNA expression in various mouse organs. Br J Pharmacol 116: 2828–2837

    CAS  PubMed  PubMed Central  Google Scholar 

  87. 87

    Namba T, Sugimoto Y, Negishi M, Irie A, Ushikubi F, Kakizuka A, Ito S, Ichikawa A, Narumiya S 1993 Alternative splicing of C-terminal tail of prostaglandin E receptor subtype EP3 determines G-protein specificity. Nature 365: 166–170

    CAS  PubMed  Google Scholar 

  88. 88

    Negishi M, Sugimoto Y, Namba T, Irie A, Narumiya S, Ichikawa A 1995 Signal transductions of three isoforms of mouse prostaglandin E receptor EP3 subtype. Adv Prostaglandin Thromboxane Leukotriene Res 23: 255–257

    CAS  Google Scholar 

  89. 89

    Riemer RK, Goldfien A, Roberts JM 1987 Estrogen increases adrenergic- but not cholinergic-mediated production of inositol phosphates in rabbit uterus. Mol Pharmacol 32: 663–668

    CAS  PubMed  Google Scholar 

  90. 90

    Riemer RK, Wu YY, Bottari SP, Jacobs MM, Goldfien A, Roberts JM 1988 Estrogen reduces β-adrenoceptor-mediated cAMP production and the concentration of the guanyl nucleotide-regulatory protein, Gs, in rabbit myometrium. Mol Pharmacol 33: 389–395

    CAS  PubMed  Google Scholar 

  91. 91

    Europe-Finner GN, Phaneuf S, Watson SP, Lopez Bernal A 1993 Identification and expression of G-proteins in human myometrium: up-regulation of Gαs in pregnancy. Endocrinology 132: 2484–2490

    CAS  PubMed  Google Scholar 

  92. 92

    Cohen-Tannoudji J, Mhaouty S, Elwardy-Merezak J, Lecrivain JL, Robin MT, Legrand C, Maltier JP 1995 Regulation of myometrial Gi2, Gi3, and Gq expression during pregnancy. Effects of progesterone and estradiol. Biol Reprod 53: 55–64

    CAS  PubMed  Google Scholar 

  93. 93

    Maggi M, Vannelli GB, Peri A, Brandi ML, Fantoni G, Giannini S, Torrisi C, Guardabasso V, Barni T, Toscano V 1991 Immunolocalization, binding, and biological activity of endothelin in rabbit uterus: effect of ovarian steroids. Am J Physiol 260: E292–E305

    CAS  PubMed  Google Scholar 

  94. 94

    Kajihara T, Tomioka Y, Hata T, Ghazizadeh M, Asano G 1996 Synthesis of endothelin-1 in rat uterus during pregnancy. J Histochem Cytochem 44: 953–957

    CAS  PubMed  Google Scholar 

  95. 95

    Yallampalli C, Garfield RE 1994 Uterine contractile responses to endothelin-1 and endothelin receptors are elevated during labor. Biol Reprod 51: 640–645

    CAS  PubMed  Google Scholar 

  96. 96

    Heluy V, Germain G, Fournier T, Ferre F, Breuiller-Fouche M 1995 Endothelin ETA receptors mediate human uterine smooth muscle contraction. Eur J Pharmacol 285: 89–94

    CAS  PubMed  Google Scholar 

  97. 97

    Maggi M, Vannelli GB, Fantoni G, Baldi E, Magini A, Peri A, Giannini S, Gloria L, Del Carlo P, Casparis D 1994 Endothelin in the human uterus during pregnancy. J Endocrinol 142: 385–396

    CAS  PubMed  Google Scholar 

  98. 98

    Svane D, Larsson B, Alm P, Andersson KE, Forman A 1993 Endothelin-1: immunocytochemistry, localization of binding sites, and contractile effects in human utero placental smooth muscle. Am J Obstet Gynecol 168: 233–241

    CAS  PubMed  Google Scholar 

  99. 99

    Csapo AI 1956 Progesterone block. Am J Anat 98: 273

    CAS  PubMed  Google Scholar 

  100. 100

    Casey ML, MacDonald PC 1996 Transforming growth factor-beta inhibits progesterone-induced enkephalinase expression in human endometrial stromal cells. J Clin Endocrinol Metab 81: 4022–4027

    CAS  PubMed  PubMed Central  Google Scholar 

  101. 101

    Olson DM, Mijovic JE, Sadowsky DW 1995 Control of human parturition. Semin Perinatol 19: 52–63

    CAS  PubMed  Google Scholar 

  102. 102

    Karalis K, Goodwin G, Majzoub JA 1996 Cortisol blockade of progesterone: a possible molecular mechanism involved in the initiation of human labor. Nat Med 2: 556–560

    CAS  PubMed  Google Scholar 

  103. 103

    McLean M, Bisits A, Davies J, Woods R, Lowry P, Smith R 1995 A placental clock controlling the length of human pregnancy. Nat Med 1: 460–463

    CAS  PubMed  PubMed Central  Google Scholar 

  104. 104

    Collins PL, Moore JJ, Idriss E, Kulp TM 1996 Human fetal membranes inhibit calcium L-channel activated uterine contractions. Am J Obstet Gynecol 175: 1173–1179

    CAS  PubMed  Google Scholar 

  105. 105

    Collins PL, Idriss E, Moore JJ 1995 Fetal membranes inhibit prostaglandin but not oxytocin-induced uterine contractions. Am J Obstet Gynecol 172: 1216–1223

    CAS  PubMed  Google Scholar 

  106. 106

    Sanborn BM, Qian A, Ku CY, Wen Y, Anwer K, Monga M, Singh SP 1995 Mechanisms regulating oxytocin receptor coupling to phospholipase C in rat and human myometrium. Adv Exp Med Biol 395: 469–479

    CAS  PubMed  Google Scholar 

  107. 107

    Liu M, Simon MI 1996 Regulation by cAMP-dependent protein kinease of a G-protein-mediated phospholipase C. Nature 382: 83–87

    CAS  PubMed  Google Scholar 

  108. 108

    Neer EJ 1995 Heterotrimeric G proteins: organizers of transmembrane signals. Cell 80: 249–257.

    CAS  PubMed  Google Scholar 

  109. 109

    Ruzycky AL, Crankshaw DJ 1988 Role of inositol phospholipid hydrolysis in the initiation of agonist-induced contractions of rat uterus: effects of domination by 17 beta-estradiol and progesterone. Can J Physiol Pharmacol 66: 10–17

    CAS  PubMed  Google Scholar 

  110. 110

    Sladek SM, Magness RR, Conrad KP 1997 Nitric oxide and pregnancy. Am J Physiol 272: R441–R463

    CAS  PubMed  Google Scholar 

  111. 111

    Bansal RK, Goldsmith PC, He Y, Zaloudek CJ, Ecker JL, Riemer RK 1997 A decline in myometrial nitric oxide synthase expression is associated with labor and delivery. J Clin Invest 99: 2502–2508

    CAS  PubMed  PubMed Central  Google Scholar 

  112. 112

    Buhimschi I, Ali M, Jain V, Chwalisz K, Garfield RE 1996 Differential regulation of nitric oxide in the rat uterus and cervix during pregnancy and labour. Hum Reprod 11: 1755–1766

    CAS  PubMed  Google Scholar 

  113. 113

    Monga M, Creasy RK 1995 Pharmacologic management of preterm labor. Semin Perinatol 19: 84–96

    CAS  PubMed  Google Scholar 

  114. 114

    Mizuki J, Tasaka K, Masumoto N, Kasahara K, Miyake A, Tanizawa O 1993 Magnesium sulfate inhibits oxytocin-induced calcium mobilization in human puerperal myometrial cells: possible involvement of intracellular free magnesium concentration. Am J Obstet Gynecol 169: 134–139

    CAS  PubMed  Google Scholar 

  115. 115

    Goodwin TM, Paul R, Silver H, Spellacy W, Parsons M, Chez R, Hayashi R, Valenzuela G, Creasy GW, Merriman R 1994 The effect of the oxytocin antagonist atosiban on preterm uterine activity in the human. Am J Obstet Gynecol 170: 474–478

    CAS  PubMed  Google Scholar 

  116. 116

    Goodwin TM, Valenzuela GJ, Silver H, Creasy G 1996 Dose ranging study of the oxytocin antagonist atosiban in the treatment of preterm labor. Atosiban Study Group. Obstet Gynecol 88: 331–336

    CAS  PubMed  Google Scholar 

  117. 117

    Modanlou HD, Beharry K, Padilla G, Iriye B 1996 Combined effects of antenatal corticosteroids and surfactant supplementation on the outcome of very low birth weight infants. J Perinatol 16: 422–430

    CAS  PubMed  Google Scholar 

  118. 118

    Clyman RI 1996 Ductus arteriosus: In: Gluckman PD, Heymann MA (eds) Pediatrics and Perinatology: The Scientific Basis. Edward Arnold, London, pp

    Google Scholar 

  119. 119

    Arslan A, Zingg HH 1996 Regulation of COX-2 gene expression in rat uterus in vivo and in vitro. Prostaglandins 52: 463–481

    CAS  PubMed  Google Scholar 

  120. 120

    Fuentes A, Spaziani EP, O'Brien WF 1996 The expression of cyclooxygenase-2 (COX-2) in amnion and decidua following spontaneous labor. Prostaglandins 52: 261–267

    CAS  PubMed  PubMed Central  Google Scholar 

  121. 121

    McManus OB, Harris GH, Giangiacomo KM, Feigenbaum P, Reuben JP, Addy ME, Burka JF, Kaczorowski GJ, Garcia ML 1993 An activator of calcium-dependent potassium channels isolated from a medicinal herb. Biochemistry 32: 6128–6133

    CAS  PubMed  Google Scholar 

  122. 122

    Kimura T, Takemura M, Nomura S, Nobunaga T, Kubota Y, Inoue T, Hashimoto K, Kumazawa I, Ito Y, Ohashi K, Koyama M, Azuma C, Kitamura Y, Saji F 1996 Expression of oxytocin receptor in human pregnant myometrium. Endocrinology 137: 780–785

    CAS  PubMed  Google Scholar 

  123. 123

    Chibbar R, Miller FD, Mitchell BF 1993 Synthesis of oxytocin in amnion, chorion, and decidua may influence the timing of human parturition. J Clin Invest 91: 185–192

    CAS  PubMed  PubMed Central  Google Scholar 

  124. 124

    Lefebvre DL, Farookhi R, Larcher A, Neculcea J, Zingg HH 1994 Uterine oxytocin gene expression. I. Induction during pseudopregnancy and the estrous cycle. Endocrinology 134: 2556–2561

    CAS  PubMed  Google Scholar 

  125. 125

    Zingg HH, Rozen F, Chu K, Larcher A, Arslan A, Richard S, Lefebvre D 1995 Oxytocin and oxytocin receptor gene expression in the uterus. Recent Prog Horm Res 50: 255–273

    CAS  PubMed  PubMed Central  Google Scholar 

  126. 126

    Mitchell BF, Chibbar R 1995 Synthesis and metabolism of oxytocin in late gestation in human decidua. Adv Exp Med Biol 395: 365–380

    CAS  PubMed  Google Scholar 

  127. 127

    Fang X, Wong S, Mitchell BF 1996 Relationships among sex steroids, oxytocin, and their receptors in the rat uterus during the late gestation and at parturition. Endocrinology 137: 3213–3219

    CAS  PubMed  Google Scholar 

  128. 128

    Casey ML, Brown CE, Peters M, MacDonald PC 1993 Endothelin levels in human amniotic fluid at mid-trimester and at term before and during spontaneous labor. J Clin Endocrinol Metab 76: 1647–1650

    CAS  PubMed  Google Scholar 

  129. 129

    MacMicking JD, Nathan C, Hom G, Chartrain N, Fletcher DS, Trumbauer M, Stevens K, Xie QW, Sokol K, Hutchinson N, Chen H, Mudgett J 1995 Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell 81: 641–650

    CAS  PubMed  Google Scholar 

  130. 130

    Laubach VE, Shesely EG, Smithies O, Sherman PA 1995 Mice lacking inducible nitric oxide synthase are not resistant to lipopolysaccharide-induced death. Proc Natl Acad Sci USA 92: 10688–10692

    CAS  PubMed  Google Scholar 

  131. 131

    Wei XQ, Charles IG, Smith A, Ure J, Feng GJ, Huang FP, Xu D, Muller W, Moncada S, Liew FY 1995 Altered immune responses in mice lacking inducible nitric oxide synthase. Nature 375: 408–411

    CAS  Google Scholar 

  132. 132

    Cobb JP, Danner RL 1996 Nitric oxide and septic shock. JAMA 275: 1192–1196

    CAS  PubMed  Google Scholar 

  133. 133

    Nishimori K, Young LJ, Guo Q, Wang Z, Insel TR, Matzuk MM 1996 Oxytocin is required for nursing but is not essential for parturition or reproductive behavior. Proc Natl Acad Sci USA 93: 11699–11704

    CAS  PubMed  PubMed Central  Google Scholar 

  134. 134

    Langenbach R, Morham SG, Tiano HF, Loftin CD, Ghanayem BI, Chulada PC, Mahler JF, Lee CA, Goulding EH, Kluckman KD, Kim HS, Smithies O 1995 Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration. Cell 83: 483–492

    CAS  PubMed  PubMed Central  Google Scholar 

  135. 135

    Morham SG, Langenbach R, Loftin CD, Tiano HF, Vouloumanos N, Jennette JC, Mahler JF, Kluckman KD, Ledford A, Lee CA, Smithies O 1995 Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse. Cell 83: 473–82

    CAS  PubMed  Google Scholar 

  136. 136

    Reaume AG, de Sousa PA, Kulkarni S, Langille BL, Zhu D, Davies TC, Juneja SC, Kidder GM, Rossant J 1995 Cardiac malformation in neonatal mice lacking connexin 43. Science 267: 1831–1834

    CAS  PubMed  Google Scholar 

  137. 137

    Lydon JP, DeMayo FJ, Funk CR, Mani SK, Hughes AR, Montgomery CA Jr, Shyamala G, Conneely OM, O'Malley BW 1995 Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities. Genes Dev 9: 2266–2278

    CAS  PubMed  Google Scholar 

  138. 138

    Lubahn DB, Moyer JS, Golding TS, Couse JF, Korach KS, Smithies O 1993 Alteration of reproductive function but not prenatal sexual development after insertional disruption of the mouse estrogen receptor gene. Proc Natl Acad Sci USA 90: 11162–11166

    CAS  PubMed  Google Scholar 

  139. 139

    Curtis SW, Washburn T, Sewall C, DiAugustine R, Lindzey J, Couse JF, Korach KS 1996 Physiological coupling of growth factor and steroid receptor signaling pathways: estrogen receptor knockout mice lack estrogen-like response to epidermal growth factor. Proc Natl Acad Sci USA 93: 12626–12630

    CAS  PubMed  Google Scholar 

  140. 140

    Davis VL, Couse JF, Goulding EH, Power SG, Eddy EM, Korach KS 1994 Aberrant reproductive phenotypes evident in transgenic mice expressing the wild-type mouse estrogen receptor. Endocrinology 135: 379–386

    CAS  PubMed  Google Scholar 

  141. 141

    Kuiper GGJM, Carlsson B, Grandien K, Enmark E, Haggblad J, Nilsson S, Gustafsson JA 1997 Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors α and β. Endocrinology 138: 863–870

    CAS  Google Scholar 

  142. 142

    Meis PJ, Goldenberg RL, Mercer B, Moawad A, Das A, McNellis D, Johnson F, Iams JD, Thom E, Andrews WW 1995 The preterm prediction study: significance of vaginal infections. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Am J Obst Gynecol 173: 1231–1235

    CAS  Google Scholar 

  143. 143

    Meis PJ, Goldenberg RL, Mercer BM, Iams JD, Moawad AH, Miodovnik M, Menard MK, Caritis SN, Thurnau GR, Bottoms SF 1998 The preterm prediction study: risk factors for indicated preterm births. Maternal-Fetal Medicine Units Network of the National Institute of Child Health and Human Development. Am J Obstet Gynecol 178: 562–567

    CAS  PubMed  Google Scholar 

  144. 144

    Wenstrom KD, Andrews WW, Hauth JC, Goldenberg RL, DuBard MB, Cliver SP 1998 Elevated second-trimester amniotic fluid interleukin-6 levels predict preterm delivery. Am J Obstet Gynecol 178: 546–550

    CAS  PubMed  Google Scholar 

  145. 145

    Goldenberg RL, Iams JD, Mercer BM, Meis PJ, Moawad AH, Copper RL, Das A, Thom E, Johnson F, McNellis D, Miodovnik M, Van Dorsten JP, Caritis SN, Thurnau GR, Bottoms SF 1998 The preterm prediction study: the value of new vs standard risk factors in predicting early and all spontaneous preterm births. NICHD MFMU Network. Am J Public Health 88: 233–238

    CAS  PubMed  PubMed Central  Google Scholar 

  146. 146

    Goldenberg RL, Thom E, Moawad AH, Johnson F, Roberts J, Caritis SN 1996 The preterm prediction study: fetal fibronectin, bacterial vaginosis, and peripartum infection. NICHD Maternal Fetal Medicine Units Network. Obstet Gynecol 87: 656–660

    CAS  PubMed  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to R Kirk Riemer.

Additional information

Supported in part by National Institutes of Health Grant HD 32518.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Riemer, R., Heymann, M. Regulation of Uterine Smooth Muscle Function during Gestation. Pediatr Res 44, 615–627 (1998). https://doi.org/10.1203/00006450-199811000-00001

Download citation

Further reading

Search